EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Menin inhibitors in the treatment of acute myeloid leukemia

Gerwin Huls, Carolien M Woolthuis iD, Jan Jacob Schuringa iD

Blood · 06.02.2025 · 145 (6) · 561-566

DOI: 10.1182/blood.2024026232 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood, erschienen am 06.02.2025. Verfasst von Gerwin Huls und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Proto-Oncogene Proteins, Antineoplastic Agents. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the (oligo)clonal expansion of myeloid progenitor cells. Despite advances in treatment, AML remains challenging to cure, particularly in patients with specific genetic abnormalities. Menin inhibitors have emerged as a promising therapeutic approach, targeting key genetic drivers of AML, such as KMT2A (lysine methyl transferase 2A) rearrangements and NPM1 mutations. Here, we review the clinical value of menin inhibitors, highlighting their mechanism of action, efficacy, safety, and potential to transform AML treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProto-Oncogene ProteinsAntineoplastic AgentsHumansNucleophosminAnimalsMutation

Substanzen

NucleophosminProto-Oncogene ProteinsMEN1 protein, humanNPM1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Carolien M Woolthuis, Jan Jacob Schuringa

Zitieren

APA

Huls, G., Woolthuis, C. M., & Schuringa, J. J. (2025). Menin inhibitors in the treatment of acute myeloid leukemia. Blood, 145(6), 561-566. https://doi.org/10.1182/blood.2024026232

Vancouver

Huls G, Woolthuis CM, Schuringa JJ. Menin inhibitors in the treatment of acute myeloid leukemia. Blood. 2025;145(6):561-566. doi:10.1182/blood.2024026232

BibTeX
@article{Huls2025,
  author = {Huls, Gerwin and Woolthuis, Carolien M and Schuringa, Jan Jacob},
  title = {Menin inhibitors in the treatment of acute myeloid leukemia},
  journal = {Blood},
  year = {2025},
  volume = {145},
  number = {6},
  pages = {561--566},
  doi = {10.1182/blood.2024026232}
}
Kostenlos starten →